相关实验视频

Updated: Sep 16, 2025

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

GDF15:从生物标志物到癌症缓解症中的标

Max Hüllwegen¹, Maximilian Kleinert², Stephan von Haehling³

¹Department of Clinical Chemistry, University Medical Center Göttingen (UMG), Göttingen, Germany.

Trends in cancer

|July 10, 2025

概括

增长分化因子15 (GDF15) 通过调节新陈代谢和免疫抑制,影响癌症缓解症. 针对GDF15在临床试验中显示出改善癌症患者治疗结果的前景.

科学领域:

在瘤学瘤学.
代谢障碍代谢障碍代谢障碍
免疫学免疫学免疫学

背景情况:

癌症缓解症是晚期癌症患者普遍存在的,使人衰弱的疾病,标志着显著的体重减轻.
目前用于癌症缓冲症的治疗方法在很大程度上是无效的,这凸显了未得到满足的临床需求.
增长分化因子15 (GDF15) 是一种已知的生物标志物,与包括癌症在内的各种疾病有关.

研究的目的:

审查目前关于GDF15在癌症缓解症中的作用的文献.
阐明GDF15影响癌症代谢和免疫抑制的机制.
突出针对癌症患者GDF15的治疗潜力.

主要方法:

关于GDF15和癌症缓存症的现有研究的文献综合.
通过后脑中的GFRAL受体对GDF15的作用机制的分析.
对GDF15向治疗的最近临床试验数据的审查.

主要成果:

GDF15在调节食物摄入量,体重和胰岛素敏感性方面发挥着关键作用.
GDF15影响瘤微环境和系统性免疫抑制.
临床试验表明,GDF15向可以提高免疫疗法疗效,体力活动,食欲和体重增加.

结论:

GDF15是癌症缓解症的关键媒介,影响了新陈代谢和免疫过程.
准GDF15通路是一个有前途的治疗策略,用于管理癌症缓解症和改善患者的生活质量.
需要对GDF15抑制剂进行进一步的研究和临床开发.

关键词:

在GDF15中,GDF15是GDF15中的一个.生物标志物生物标志物卡赫西亚 (Cachexia) 是一种缓解症.癌症癌症癌症癌症癌症免疫抑制是一种免疫抑制.代谢代谢代谢代谢

更多相关视频

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Automated Preparation of [⁶⁸Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...